Amneal (AMRX) EVP Jason B. Daly Sells 216,613 Shares

What Happened
Jason B. Daly, EVP and Chief Legal Officer of Amneal Pharmaceuticals (AMRX), sold a total of 216,613 shares in two reported transactions. On 2026-08-11 he sold 6,613 shares at a weighted average price of $17.70 for proceeds of $117,050; on 2026-08-12 he sold 210,000 shares at a weighted average price of $17.40 for proceeds of $3,654,000. Total reported proceeds across both sales were approximately $3,771,050. These were sales (not purchases), which are often routine liquidity transactions rather than an indicator of company outlook.

Key Details

• Transaction dates: 2026-08-11 (6,613 shares) and 2026-08-12 (210,000 shares).
• Reported weighted-average prices and proceeds: $17.70 → $117,050 (8/11); $17.40 → $3,654,000 (8/12); combined ≈ $3,771,050.
• Footnotes: Prices are weighted averages from multiple trades. 8/11 trades ranged $17.65–$17.73 (F1); 8/12 trades ranged $17.25–$17.67 (F2). Reporting person will provide per-trade breakdown to Amneal or SEC staff on request.
• Transaction type: Marked "S" (open market or private sale). No 10b5-1 plan, option exercise, gift, or tax-withholding note was indicated in the provided filing.
• Shares owned after transaction: Not disclosed in the information supplied here.
• Timeliness: Form 4 was filed on 2026-08-13 for trades on 8/11–8/12—filed within the typical two-business-day reporting window.

Context
Sales by executives can reflect routine portfolio or liquidity needs and do not by themselves indicate a change in company fundamentals. This filing documents cash sales (not option exercises or awards). If you want per-trade pricing or ownership-after-sale details, those can be requested from Amneal or obtained from the full SEC Form 4 filing (Accession: 0001628280-26-056754).